Cancer Policy: A Complex Web of Prevention, Treatment, and Advocacy

Cancer policy encompasses a broad range of issues, from prevention and early detection to treatment access and palliative care. The World Health Organization (WHO) estimates that approximately 10 million people died from cancer in 2020, with this number projected to rise to 16 million by 2040. In the United States, the Affordable Care Act (ACA) has expanded health insurance coverage for millions, including those with cancer, but debates over healthcare reform continue to impact cancer policy. The American Cancer Society (ACS) and other advocacy groups play crucial roles in shaping policy, with initiatives like the ACS's Cancer Action Network (CAN) working to influence legislative decisions. As cancer research advances, policymakers must balance the costs of new treatments with the need for equitable access, a challenge that will only intensify as the global cancer burden grows. By 2025, the global cost of cancer is expected to exceed $1 trillion, underscoring the urgent need for effective, sustainable cancer policies.